pharmaphorum

NOVEMBER 19, 2021

The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic. Two casualties of the Pfizer/BioNTech and Moderna success, however, have been Sanofi and CureVac, both firms dropping their mRNA shots. So too are the sales figures.

Sales 136

Sales Vaccination Vaccine Marketing 136

pharmaphorum

DECEMBER 2, 2020

And with the company becoming one of the first in the world to get a COVID-19 vaccine approved – via its collaboration with BioNTech – it feels like we’re only on the cusp of seeing where the company could head in the future. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag.

Sales 128

Sales Production Drugs Marketing 128

XTalks

NOVEMBER 27, 2021

The technical advisory group on SARS-CoV-2 virus evolution (TAG-VE) met on Friday to discuss B.1.1.529, Related: FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Kids 5 to 11. The World Health Organization (WHO) has declared the new variant of SARS-CoV-2 found in South Africa, first referred to as B.1.1.529,

Vaccination 97

Vaccination Vaccine Protein Scientist 97

The Pharma Data

MAY 4, 2021

It also includes R&D expenses related to other mRNA-based development programs which are excluded from the collaboration with BioNTech. It does not include an allocation of corporate or other overhead costs. Clinical and Research Developments. and South African variants.

Vaccination 40

Vaccination Vaccine Production Sales 40

The Pharma Data

MAY 5, 2021

BioNTech on course to produce three billion doses of Pfizer-partnered COVID-19 vaccine in 2021 ( PMLive ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). Nasal spray shown to be effective in reducing COVID-19 transmission ( EPR ).

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52